Sun Pharma: USFDA classifies Halol facility as Official Action Indicated Medical Dialogues Bureau30 March 2020 7:48 AM GMTMumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as '...
Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each Medical Dialogues Bureau17 March 2020 11:48 AM GMTNew Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a maxim...
Shortage of generic version of BP drug pindolol, says Sun Pharma Medical Dialogues Bureau3 March 2020 7:06 AM GMTThe coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to ...
